Showing 621 - 640 of 1378 results
Tobacco plant has potential to fight life-threatening infectious diseases
Protein found in tobacco plant can target and kill microorganisms,
Nuclear Medicine
Faisal studied Electrical engineering at the University of Queensland and started their career in a role that specialised in integration of control systems in factories, large-scale rock crushing machinery, and marine luxury yachts.
Japanese press release featuring work done at OPAL
ANSTO's National Science Week events
National Science Week is a time to celebrate science and the important role national science agencies like ANSTO play in delivering outcomes that benefit all Australians.
Clarity Pharmaceuticals raises $1.1 million
Peak Resources commissions ANSTO Minerals to operate Ngualla Rare Earths Pilot Plant
As a result of the successful optimisation testwork, Peak Resources has commissioned ANSTO Minerals to operate the pilot plant to validate the optimised “Alkali Roast” process flowsheet that has been selected by Peak for the Bankable Feasibility Study. The study is expected to be completed by early 2017.
Group Executive Nuclear Safety, Security and Stewardship
In June 2022 Miles was appointed to a new role of Group Executive Nuclear Safety, Security and Stewardship with responsibility for all nuclear safety and security operations at ANSTO as well as coordination of al
Biologist
Role at ANSTO
ANSTO welcomes appointment of CEO for the Australian radioactive waste agency
ANSTO welcomes the recent announcement that the inaugural CEO for the Australian Radioactive Waste Agency (ARWA) has been appointed, following a global search. Mr Sam Usher will lead ARWA and comes to the role with almost three decades of experience in the nuclear industry.
ANSTO facilities and expertise supply a large range of radioisotopes for radiopharmaceutical and environmental applications
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
ANSTO scientists share thoughts on Oppenheimer film
Radiochemist
Krishant holds a PhD in Medicinal Chemistry, specialising in the design and development of novel platinum(IV)-based anticancer agents, where he has contributed to the development of a new class of compounds that is currently undergoing p
Scientific Officer, Australian Museum
Tara Djokic is a geologist currently based in the Palaeontology Department of the Australian Museum Research Institute where she is investigating the fossilisation processes of an 11-16 million-year-old rainforest-lake deposit from central N
ANSTO delivers custom tailored radioisotopes bound for space applications with tech incubator entX
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Agreement bolsters nuclear science education in South Korea
Sustainability expert joins ANSTO's Innovation Precinct
Dr Anne Hellstedt has been appointed Director of ANSTO’s Innovation Precinct.
Federal grants for ANSTO expertise and infrastructure will benefit manufacturing and nuclear technologies
Three new federal grants were announced to support manufacturing and nuclear technologies.
Grant Success
Both the Australian Centre for Neutron Scattering and the National Deuteration Facility share in grants
Successful clinical trial for prostate cancer enabled by ANSTO
The new targeted treatment for aggressive prostate cancer, which include lutetium produced at ANSTO, has shown to produce more potent and durable responses in men and with fewer side-effects.